+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Leptospirosis Vaccine Market - Global Forecast 2025-2030- Product Image
Leptospirosis Vaccine Market - Global Forecast 2025-2030- Product Image
Sale

Leptospirosis Vaccine Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 188 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6145863
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Leptospirosis Vaccine market is undergoing significant transformation as regulators, industry leaders, and technology innovators address persistent threats to animal health and agricultural productivity. Stakeholders are actively deploying solutions that improve prophylactic coverage, streamline supply chains, and adapt to evolving disease dynamics.

Market Snapshot: Leptospirosis Vaccine Market

The global Leptospirosis Vaccine market is characterized by a rapidly expanding footprint, underpinned by technological advancements, expanding regulatory frameworks, and shifting distribution models. Demand is rising across commercial farming, veterinary clinics, and ancillary channels as pandemic preparedness and One Health priorities gain traction industry-wide. Notably, new tariff measures introduced in the United States in 2025 have prompted immediate recalibration of supply chain strategies and pricing structures.

Scope & Segmentation

This comprehensive report analyzes the Leptospirosis Vaccine market across a broad range of strategic segments and regions, integrating the latest trends and product innovations. The market is segmented as follows:

  • Animal Species: Canine, Cattle, Equine, Swine
  • Vaccine Types: Inactivated (Fractional, Whole Cell), Live Attenuated, Recombinant (DNA, Subunit)
  • Distribution Channels: Hospital Pharmacies, Online Stores, Retail Pharmacies, Veterinary Clinics
  • End Users: Commercial Farms, Diagnostic Laboratories, Research Institutes, Veterinary Hospitals
  • Routes of Administration: Intramuscular, Oral, Subcutaneous
  • Dose Forms: Liquid, Lyophilized
  • Regions & Notable Markets: United States, Canada, Mexico, Brazil, Argentina, United Kingdom, Germany, France, Russia, Italy, Spain, United Arab Emirates, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland, China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan
  • Profiled Companies: Zoetis Inc., Merck & Co., Inc., Boehringer Ingelheim International GmbH, Elanco Animal Health Incorporated, CEVA SANTE ANIMALE S.A., Laboratorios Hipra, S.A., IDT Biologika GmbH, VAXXINOVA GmbH, Indian Immunologicals Limited, Anhui Zhonglong Bio-science Stock Co., Ltd.

Key Takeaways for Senior Decision-Makers

  • Breakthrough recombinant platforms and subunit formulations enhance immunogenicity while refined inactivated methods improve safety, appealing to both advanced and cost-sensitive markets.
  • Regulatory harmonization across major regions accelerates approval while fostering new collaboration models among manufacturers, research entities, and technology licensors.
  • Recent US tariff measures on vaccine inputs have amplified interest in localized manufacturing and dual-sourcing models, supporting resilience and long-term supply stability.
  • Cold chain innovations and lyophilized dose forms are expanding reach to underserved rural and remote farming communities through both traditional and digital distribution channels.
  • Species-specific demand patterns and administration preferences are influencing tailored vaccine design, driving segment-specific go-to-market strategies for commercial farms and clinics.
  • Strategic collaborations, co-development initiatives, and regional public-private partnerships are shaping future product pipelines and competitive dynamics.

Tariff Impact on Leptospirosis Vaccine Market

The imposition of new tariff measures in the United States in 2025 has increased production costs for vaccine manufacturers reliant on imported materials and adjuvants. In response, industry leaders are intensifying localization of supply chains, repurposing domestic facilities, and hedging risk through diversified sourcing. These shifts have triggered pricing recalibrations across the supply chain and stimulated dialogue with commercial farms, research institutes, and veterinary hospitals to maintain affordable preventive coverage, with a pronounced focus on supply chain resilience.

Methodology & Data Sources

This report utilizes a mixed-methods approach, drawing from in-depth interviews with veterinary experts, supply chain analysts, and regulatory specialists. Quantitative market surveys supplement qualitative findings, while peer-reviewed publications, regulatory filings, and patent data support our comprehensive market mapping. Advanced analytics and scenario modeling further strengthen the credibility of insights and forecasts.

Why This Report Matters

  • Gain a holistic understanding of market drivers, evolving technology platforms, and supply chain strategies underpinning the Leptospirosis Vaccine sector.
  • Inform product development, go-to-market plans, and investment decisions with timely analysis of regulatory, regional, and commercial trends.
  • Leverage actionable intelligence to strengthen organizational resilience in the face of shifting policy environments and disease outbreaks.

Conclusion

The Leptospirosis Vaccine market continues to evolve through technological progress, regulatory adaptation, and targeted distribution. Stakeholders who align strategy with these market trends are positioned to deliver impactful, sustainable solutions supporting both animal and public health.



This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Rising demand for multi-valent Leptospirosis vaccines targeting prevalent serovars in tropical regions
5.2. Implementation of advanced adjuvant technologies to improve immune response durability in Leptospirosis vaccines
5.3. Strategic collaborations between biotechnology firms and research institutes for accelerated clinical trials of novel Leptospirosis vaccines
5.4. Growing market access initiatives in endemic countries supported by government vaccination campaigns and funding schemes
5.5. Increasing emphasis on cost-effective manufacturing processes for large-scale Leptospirosis vaccine production in emerging markets
5.6. Regulatory framework evolution focusing on accelerated approval pathways for next-generation Leptospirosis vaccine candidates
5.7. Integration of next-generation sequencing data to identify cross-protective antigens for universal Leptospirosis vaccine development
5.8. Rising interest in needle-free delivery systems and oral Leptospirosis vaccines to improve patient compliance and distribution logistics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Leptospirosis Vaccine Market, by Animal Species
8.1. Introduction
8.2. Canine
8.3. Cattle
8.4. Equine
8.5. Swine
9. Leptospirosis Vaccine Market, by Vaccine Type
9.1. Introduction
9.2. Inactivated
9.2.1. Fractional
9.2.2. Whole Cell
9.3. Live Attenuated
9.4. Recombinant
9.4.1. DNA
9.4.2. Subunit
10. Leptospirosis Vaccine Market, by Distribution Channel
10.1. Introduction
10.2. Hospital Pharmacies
10.3. Online Stores
10.4. Retail Pharmacies
10.5. Veterinary Clinics
11. Leptospirosis Vaccine Market, by End User
11.1. Introduction
11.2. Commercial Farms
11.3. Diagnostic Laboratories
11.4. Research Institutes
11.5. Veterinary Hospitals
12. Leptospirosis Vaccine Market, by Route Of Administration
12.1. Introduction
12.2. Intramuscular
12.3. Oral
12.4. Subcutaneous
13. Leptospirosis Vaccine Market, by Dose Form
13.1. Introduction
13.2. Liquid
13.3. Lyophilized
14. Americas Leptospirosis Vaccine Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Leptospirosis Vaccine Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Leptospirosis Vaccine Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Zoetis Inc.
17.3.2. Merck & Co., Inc.
17.3.3. Boehringer Ingelheim International GmbH
17.3.4. Elanco Animal Health Incorporated
17.3.5. CEVA SANTE ANIMALE S.A.
17.3.6. Laboratorios Hipra, S.A.
17.3.7. IDT Biologika GmbH
17.3.8. VAXXINOVA GmbH
17.3.9. Indian Immunologicals Limited
17.3.10. Anhui Zhonglong Bio-science Stock Co., Ltd.
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. LEPTOSPIROSIS VACCINE MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL LEPTOSPIROSIS VACCINE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL LEPTOSPIROSIS VACCINE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL LEPTOSPIROSIS VACCINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL LEPTOSPIROSIS VACCINE MARKET SIZE, BY ANIMAL SPECIES, 2024 VS 2030 (%)
FIGURE 6. GLOBAL LEPTOSPIROSIS VACCINE MARKET SIZE, BY ANIMAL SPECIES, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL LEPTOSPIROSIS VACCINE MARKET SIZE, BY VACCINE TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL LEPTOSPIROSIS VACCINE MARKET SIZE, BY VACCINE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL LEPTOSPIROSIS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 10. GLOBAL LEPTOSPIROSIS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL LEPTOSPIROSIS VACCINE MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL LEPTOSPIROSIS VACCINE MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL LEPTOSPIROSIS VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 14. GLOBAL LEPTOSPIROSIS VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL LEPTOSPIROSIS VACCINE MARKET SIZE, BY DOSE FORM, 2024 VS 2030 (%)
FIGURE 16. GLOBAL LEPTOSPIROSIS VACCINE MARKET SIZE, BY DOSE FORM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS LEPTOSPIROSIS VACCINE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS LEPTOSPIROSIS VACCINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES LEPTOSPIROSIS VACCINE MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES LEPTOSPIROSIS VACCINE MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA LEPTOSPIROSIS VACCINE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA LEPTOSPIROSIS VACCINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC LEPTOSPIROSIS VACCINE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC LEPTOSPIROSIS VACCINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. LEPTOSPIROSIS VACCINE MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. LEPTOSPIROSIS VACCINE MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 27. LEPTOSPIROSIS VACCINE MARKET: RESEARCHAI
FIGURE 28. LEPTOSPIROSIS VACCINE MARKET: RESEARCHSTATISTICS
FIGURE 29. LEPTOSPIROSIS VACCINE MARKET: RESEARCHCONTACTS
FIGURE 30. LEPTOSPIROSIS VACCINE MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. LEPTOSPIROSIS VACCINE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL LEPTOSPIROSIS VACCINE MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL LEPTOSPIROSIS VACCINE MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL LEPTOSPIROSIS VACCINE MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL LEPTOSPIROSIS VACCINE MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL LEPTOSPIROSIS VACCINE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL LEPTOSPIROSIS VACCINE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL LEPTOSPIROSIS VACCINE MARKET SIZE, BY ANIMAL SPECIES, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL LEPTOSPIROSIS VACCINE MARKET SIZE, BY ANIMAL SPECIES, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL LEPTOSPIROSIS VACCINE MARKET SIZE, BY CANINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL LEPTOSPIROSIS VACCINE MARKET SIZE, BY CANINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL LEPTOSPIROSIS VACCINE MARKET SIZE, BY CATTLE, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL LEPTOSPIROSIS VACCINE MARKET SIZE, BY CATTLE, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL LEPTOSPIROSIS VACCINE MARKET SIZE, BY EQUINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL LEPTOSPIROSIS VACCINE MARKET SIZE, BY EQUINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL LEPTOSPIROSIS VACCINE MARKET SIZE, BY SWINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL LEPTOSPIROSIS VACCINE MARKET SIZE, BY SWINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL LEPTOSPIROSIS VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL LEPTOSPIROSIS VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL LEPTOSPIROSIS VACCINE MARKET SIZE, BY INACTIVATED, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL LEPTOSPIROSIS VACCINE MARKET SIZE, BY INACTIVATED, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL LEPTOSPIROSIS VACCINE MARKET SIZE, BY FRACTIONAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL LEPTOSPIROSIS VACCINE MARKET SIZE, BY FRACTIONAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL LEPTOSPIROSIS VACCINE MARKET SIZE, BY WHOLE CELL, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL LEPTOSPIROSIS VACCINE MARKET SIZE, BY WHOLE CELL, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL LEPTOSPIROSIS VACCINE MARKET SIZE, BY INACTIVATED, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL LEPTOSPIROSIS VACCINE MARKET SIZE, BY INACTIVATED, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL LEPTOSPIROSIS VACCINE MARKET SIZE, BY LIVE ATTENUATED, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL LEPTOSPIROSIS VACCINE MARKET SIZE, BY LIVE ATTENUATED, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL LEPTOSPIROSIS VACCINE MARKET SIZE, BY RECOMBINANT, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL LEPTOSPIROSIS VACCINE MARKET SIZE, BY RECOMBINANT, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL LEPTOSPIROSIS VACCINE MARKET SIZE, BY DNA, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL LEPTOSPIROSIS VACCINE MARKET SIZE, BY DNA, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL LEPTOSPIROSIS VACCINE MARKET SIZE, BY SUBUNIT, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL LEPTOSPIROSIS VACCINE MARKET SIZE, BY SUBUNIT, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL LEPTOSPIROSIS VACCINE MARKET SIZE, BY RECOMBINANT, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL LEPTOSPIROSIS VACCINE MARKET SIZE, BY RECOMBINANT, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL LEPTOSPIROSIS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL LEPTOSPIROSIS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL LEPTOSPIROSIS VACCINE MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL LEPTOSPIROSIS VACCINE MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL LEPTOSPIROSIS VACCINE MARKET SIZE, BY ONLINE STORES, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL LEPTOSPIROSIS VACCINE MARKET SIZE, BY ONLINE STORES, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL LEPTOSPIROSIS VACCINE MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL LEPTOSPIROSIS VACCINE MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL LEPTOSPIROSIS VACCINE MARKET SIZE, BY VETERINARY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL LEPTOSPIROSIS VACCINE MARKET SIZE, BY VETERINARY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL LEPTOSPIROSIS VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL LEPTOSPIROSIS VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL LEPTOSPIROSIS VACCINE MARKET SIZE, BY COMMERCIAL FARMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL LEPTOSPIROSIS VACCINE MARKET SIZE, BY COMMERCIAL FARMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL LEPTOSPIROSIS VACCINE MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL LEPTOSPIROSIS VACCINE MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL LEPTOSPIROSIS VACCINE MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL LEPTOSPIROSIS VACCINE MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL LEPTOSPIROSIS VACCINE MARKET SIZE, BY VETERINARY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL LEPTOSPIROSIS VACCINE MARKET SIZE, BY VETERINARY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL LEPTOSPIROSIS VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL LEPTOSPIROSIS VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL LEPTOSPIROSIS VACCINE MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL LEPTOSPIROSIS VACCINE MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL LEPTOSPIROSIS VACCINE MARKET SIZE, BY ORAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL LEPTOSPIROSIS VACCINE MARKET SIZE, BY ORAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL LEPTOSPIROSIS VACCINE MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL LEPTOSPIROSIS VACCINE MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL LEPTOSPIROSIS VACCINE MARKET SIZE, BY DOSE FORM, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL LEPTOSPIROSIS VACCINE MARKET SIZE, BY DOSE FORM, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL LEPTOSPIROSIS VACCINE MARKET SIZE, BY LIQUID, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL LEPTOSPIROSIS VACCINE MARKET SIZE, BY LIQUID, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL LEPTOSPIROSIS VACCINE MARKET SIZE, BY LYOPHILIZED, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL LEPTOSPIROSIS VACCINE MARKET SIZE, BY LYOPHILIZED, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. AMERICAS LEPTOSPIROSIS VACCINE MARKET SIZE, BY ANIMAL SPECIES, 2018-2024 (USD MILLION)
TABLE 74. AMERICAS LEPTOSPIROSIS VACCINE MARKET SIZE, BY ANIMAL SPECIES, 2025-2030 (USD MILLION)
TABLE 75. AMERICAS LEPTOSPIROSIS VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 76. AMERICAS LEPTOSPIROSIS VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 77. AMERICAS LEPTOSPIROSIS VACCINE MARKET SIZE, BY INACTIVATED, 2018-2024 (USD MILLION)
TABLE 78. AMERICAS LEPTOSPIROSIS VACCINE MARKET SIZE, BY INACTIVATED, 2025-2030 (USD MILLION)
TABLE 79. AMERICAS LEPTOSPIROSIS VACCINE MARKET SIZE, BY RECOMBINANT, 2018-2024 (USD MILLION)
TABLE 80. AMERICAS LEPTOSPIROSIS VACCINE MARKET SIZE, BY RECOMBINANT, 2025-2030 (USD MILLION)
TABLE 81. AMERICAS LEPTOSPIROSIS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 82. AMERICAS LEPTOSPIROSIS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 83. AMERICAS LEPTOSPIROSIS VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 84. AMERICAS LEPTOSPIROSIS VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 85. AMERICAS LEPTOSPIROSIS VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 86. AMERICAS LEPTOSPIROSIS VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 87. AMERICAS LEPTOSPIROSIS VACCINE MARKET SIZE, BY DOSE FORM, 2018-2024 (USD MILLION)
TABLE 88. AMERICAS LEPTOSPIROSIS VACCINE MARKET SIZE, BY DOSE FORM, 2025-2030 (USD MILLION)
TABLE 89. AMERICAS LEPTOSPIROSIS VACCINE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 90. AMERICAS LEPTOSPIROSIS VACCINE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 91. UNITED STATES LEPTOSPIROSIS VACCINE MARKET SIZE, BY ANIMAL SPECIES, 2018-2024 (USD MILLION)
TABLE 92. UNITED STATES LEPTOSPIROSIS VACCINE MARKET SIZE, BY ANIMAL SPECIES, 2025-2030 (USD MILLION)
TABLE 93. UNITED STATES LEPTOSPIROSIS VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 94. UNITED STATES LEPTOSPIROSIS VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 95. UNITED STATES LEPTOSPIROSIS VACCINE MARKET SIZE, BY INACTIVATED, 2018-2024 (USD MILLION)
TABLE 96. UNITED STATES LEPTOSPIROSIS VACCINE MARKET SIZE, BY INACTIVATED, 2025-2030 (USD MILLION)
TABLE 97. UNITED STATES LEPTOSPIROSIS VACCINE MARKET SIZE, BY RECOMBINANT, 2018-2024 (USD MILLION)
TABLE 98. UNITED STATES LEPTOSPIROSIS VACCINE MARKET SIZE, BY RECOMBINANT, 2025-2030 (USD MILLION)
TABLE 99. UNITED STATES LEPTOSPIROSIS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 100. UNITED STATES LEPTOSPIROSIS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 101. UNITED STATES LEPTOSPIROSIS VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 102. UNITED STATES LEPTOSPIROSIS VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 103. UNITED STATES LEPTOSPIROSIS VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 104. UNITED STATES LEPTOSPIROSIS VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 105. UNITED STATES LEPTOSPIROSIS VACCINE MARKET SIZE, BY DOSE FORM, 2018-2024 (USD MILLION)
TABLE 106. UNITED STATES LEPTOSPIROSIS VACCINE MARKET SIZE, BY DOSE FORM, 2025-2030 (USD MILLION)
TABLE 107. UNITED STATES LEPTOSPIROSIS VACCINE MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 108. UNITED STATES LEPTOSPIROSIS VACCINE MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 109. CANADA LEPTOSPIROSIS VACCINE MARKET SIZE, BY ANIMAL SPECIES, 2018-2024 (USD MILLION)
TABLE 110. CANADA LEPTOSPIROSIS VACCINE MARKET SIZE, BY ANIMAL SPECIES, 2025-2030 (USD MILLION)
TABLE 111. CANADA LEPTOSPIROSIS VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 112. CANADA LEPTOSPIROSIS VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 113. CANADA LEPTOSPIROSIS VACCINE MARKET SIZE, BY INACTIVATED, 2018-2024 (USD MILLION)
TABLE 114. CANADA LEPTOSPIROSIS VACCINE MARKET SIZE, BY INACTIVATED, 2025-2030 (USD MILLION)
TABLE 115. CANADA LEPTOSPIROSIS VACCINE MARKET SIZE, BY RECOMBINANT, 2018-2024 (USD MILLION)
TABLE 116. CANADA LEPTOSPIROSIS VACCINE MARKET SIZE, BY RECOMBINANT, 2025-2030 (USD MILLION)
TABLE 117. CANADA LEPTOSPIROSIS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 118. CANADA LEPTOSPIROSIS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 119. CANADA LEPTOSPIROSIS VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 120. CANADA LEPTOSPIROSIS VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 121. CANADA LEPTOSPIROSIS VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 122. CANADA LEPTOSPIROSIS VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 123. CANADA LEPTOSPIROSIS VACCINE MARKET SIZE, BY DOSE FORM, 2018-2024 (USD MILLION)
TABLE 124. CANADA LEPTOSPIROSIS VACCINE MARKET SIZE, BY DOSE FORM, 2025-2030 (USD MILLION)
TABLE 125. MEXICO LEPTOSPIROSIS VACCINE MARKET SIZE, BY ANIMAL SPECIES, 2018-2024 (USD MILLION)
TABLE 126. MEXICO LEPTOSPIROSIS VACCINE MARKET SIZE, BY ANIMAL SPECIES, 2025-2030 (USD MILLION)
TABLE 127. MEXICO LEPTOSPIROSIS VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 128. MEXICO LEPTOSPIROSIS VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 129. MEXICO LEPTOSPIROSIS VACCINE MARKET SIZE, BY INACTIVATED, 2018-2024 (USD MILLION)
TABLE 130. MEXICO LEPTOSPIROSIS VACCINE MARKET SIZE, BY INACTIVATED, 2025-2030 (USD MILLION)
TABLE 131. MEXICO LEPTOSPIROSIS VACCINE MARKET SIZE, BY RECOMBINANT, 2018-2024 (USD MILLION)
TABLE 132. MEXICO LEPTOSPIROSIS VACCINE MARKET SIZE, BY RECOMBINANT, 2025-2030 (USD MILLION)
TABLE 133. MEXICO LEPTOSPIROSIS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 134. MEXICO LEPTOSPIROSIS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 135. MEXICO LEPTOSPIROSIS VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 136. MEXICO LEPTOSPIROSIS VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 137. MEXICO LEPTOSPIROSIS VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 138. MEXICO LEPTOSPIROSIS VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 139. MEXICO LEPTOSPIROSIS VACCINE MARKET SIZE, BY DOSE FORM, 2018-2024 (USD MILLION)
TABLE 140. MEXICO LEPTOSPIROSIS VACCINE MARKET SIZE, BY DOSE FORM, 2025-2030 (USD MILLION)
TABLE 141. BRAZIL LEPTOSPIROSIS VACCINE MARKET SIZE, BY ANIMAL SPECIES, 2018-2024 (USD MILLION)
TABLE 142. BRAZIL LEPTOSPIROSIS VACCINE MARKET SIZE, BY ANIMAL SPECIES, 2025-2030 (USD MILLION)
TABLE 143. BRAZIL LEPTOSPIROSIS VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 144. BRAZIL LEPTOSPIROSIS VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 145. BRAZIL LEPTOSPIROSIS VACCINE MARKET SIZE, BY INACTIVATED, 2018-2024 (USD MILLION)
TABLE 146. BRAZIL LEPTOSPIROSIS VACCINE MARKET SIZE, BY INACTIVATED, 2025-2030 (USD MILLION)
TABLE 147. BRAZIL LEPTOSPIROSIS VACCINE MARKET SIZE, BY RECOMBINANT, 2018-2024 (USD MILLION)
TABLE 148. BRAZIL LEPTOSPIROSIS VACCINE MARKET SIZE, BY RECOMBINANT, 2025-2030 (USD MILLION)
TABLE 149. BRAZIL LEPTOSPIROSIS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 150. BRAZIL LEPTOSPIROSIS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 151. BRAZIL LEPTOSPIROSIS VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 152. BRAZIL LEPTOSPIROSIS VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 153. BRAZIL LEPTOSPIROSIS VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 154. BRAZIL LEPTOSPIROSIS VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 155. BRAZIL LEPTOSPIROSIS VACCINE MARKET SIZE, BY DOSE FORM, 2018-2024 (USD MILLION)
TABLE 156. BRAZIL LEPTOSPIROSIS VACCINE MARKET SIZE, BY DOSE FORM, 2025-2030 (USD MILLION)
TABLE 157. ARGENTINA LEPTOSPIROSIS VACCINE MARKET SIZE, BY ANIMAL SPECIES, 2018-2024 (USD MILLION)
TABLE 158. ARGENTINA LEPTOSPIROSIS VACCINE MARKET SIZE, BY ANIMAL SPECIES, 2025-2030 (USD MILLION)
TABLE 159. ARGENTINA LEPTOSPIROSIS VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 160. ARGENTINA LEPTOSPIROSIS VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 161. ARGENTINA LEPTOSPIROSIS VACCINE MARKET SIZE, BY INACTIVATED, 2018-2024 (USD MILLION)
TABLE 162. ARGENTINA LEPTOSPIROSIS VACCINE MARKET SIZE, BY INACTIVATED, 2025-2030 (USD MILLION)
TABLE 163. ARGENTINA LEPTOSPIROSIS VACCINE MARKET SIZE, BY RECOMBINANT, 2018-2024 (USD MILLION)
TABLE 164. ARGENTINA LEPTOSPIROSIS VACCINE MARKET SIZE, BY RECOMBINANT, 2025-2030 (USD MILLION)
TABLE 165. ARGENTINA LEPTOSPIROSIS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 166. ARGENTINA LEPTOSPIROSIS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 167. ARGENTINA LEPTOSPIROSIS VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 168. ARGENTINA LEPTOSPIROSIS VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 169. ARGENTINA LEPTOSPIROSIS VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 170. ARGENTINA LEPTOSPIROSIS VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 171. ARGENTINA LEPTOSPIROSIS VACCINE MARKET SIZE, BY DOSE FORM, 2018-2024 (USD MILLION)
TABLE 172. ARGENTINA LEPTOSPIROSIS VACCINE MARKET SIZE, BY DOSE FORM, 2025-2030 (USD MILLION)
TABLE 173. EUROPE, MIDDLE EAST & AFRICA LEPTOSPIROSIS VACCINE MARKET SIZE, BY ANIMAL SPECIES, 2018-2024 (USD MILLION)
TABLE 174. EUROPE, MIDDLE EAST & AFRICA LEPTOSPIROSIS VACCINE MARKET SIZE, BY ANIMAL SPECIES, 2025-2030 (USD MILLION)
TABLE 175. EUROPE, MIDDLE EAST & AFRICA LEPTOSPIROSIS VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 176. EUROPE, MIDDLE EAST & AFRICA LEPTOSPIROSIS VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 177. EUROPE, MIDDLE EAST & AFRICA LEPTOSPIROSIS VACCINE MARKET SIZE, BY INACTIVATED, 2018-2024 (USD MILLION)
TABLE 178. EUROPE, MIDDLE EAST & AFRICA LEPTOSPIROSIS VACCINE MARKET SIZE, BY INACTIVATED, 2025-2030 (USD MILLION)
TABLE 179. EUROPE, MIDDLE EAST & AFRICA LEPTOSPIROSIS VACCINE MARKET SIZE, BY RECOMBINANT, 2018-2024 (USD MILLION)
TABLE 180. EUROPE, MIDDLE EAST & AFRICA LEPTOSPIROSIS VACCINE MARKET SIZE, BY RECOMBINANT, 2025-2030 (USD MILLION)
TABLE 181. EUROPE, MIDDLE EAST & AFRICA LEPTOSPIROSIS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 182. EUROPE, MIDDLE EAST & AFRICA LEPTOSPIROSIS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 183. EUROPE, MIDDLE EAST & AFRICA LEPTOSPIROSIS VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 184. EUROPE, MIDDLE EAST & AFRICA LEPTOSPIROSIS VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 185. EUROPE, MIDDLE EAST & AFRICA LEPTOSPIROSIS VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 186. EUROPE, MIDDLE EAST & AFRICA LEPTOSPIROSIS VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 187. EUROPE, MIDDLE EAST & AFRICA LEPTOSPIROSIS VACCINE MARKET SIZE, BY DOSE FORM, 2018-2024 (USD MILLION)
TABLE 188. EUROPE, MIDDLE EAST & AFRICA LEPTOSPIROSIS VACCINE MARKET SIZE, BY DOSE FORM, 2025-2030 (USD MILLION)
TABLE 189. EUROPE, MIDDLE EAST & AFRICA LEPTOSPIROSIS VACCINE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 190. EUROPE, MIDDLE EAST & AFRICA LEPTOSPIROSIS VACCINE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 191. UNITED KINGDOM LEPTOSPIROSIS VACCINE MARKET SIZE, BY ANIMAL SPECIES, 2018-2024 (USD MILLION)
TABLE 192. UNITED KINGDOM LEPTOSPIROSIS VACCINE MARKET SIZE, BY ANIMAL SPECIES, 2025-2030 (USD MILLION)
TABLE 193. UNITED KINGDOM LEPTOSPIROSIS VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 194. UNITED KINGDOM LEPTOSPIROSIS VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 195. UNITED KINGDOM LEPTOSPIROSIS VACCINE MARKET SIZE, BY INACTIVATED, 2018-2024 (USD MILLION)
TABLE 196. UNITED KINGDOM LEPTOSPIROSIS VACCINE MARKET SIZE, BY INACTIVATED, 2025-2030 (USD MILLION)
TABLE 197. UNITED KINGDOM LEPTOSPIROSIS VACCINE MARKET SIZE, BY RECOMBINANT, 2018-2024 (USD MILLION)
TABLE 198. UNITED KINGDOM LEPTOSPIROSIS VACCINE MARKET SIZE, BY RECOMBINANT, 2025-2030 (USD MILLION)
TABLE 199. UNITED KINGDOM LEPTOSPIROSIS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 200. UNITED KINGDOM LEPTOSPIROSIS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 201. UNITED KINGDOM LEPTOSPIROSIS VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 202. UNITED KINGDOM LEPTOSPIROSIS VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 203. UNITED KINGDOM LEPTOSPIROSIS VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 204. UNITED KINGDOM LEPTOSPIROSIS VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 205. UNITED KINGDOM LEPTOSPIROSIS VACCINE MARKET SIZE, BY DOSE FORM, 2018-2024 (USD MILLION)
TABLE 206. UNITED KINGDOM LEPTOSPIROSIS VACCINE MARKET SIZE, BY DOSE FORM, 2025-2030 (USD MILLION)
TABLE 207. GERMANY LEPTOSPIROSIS VACCINE MARKET SIZE, BY ANIMAL SPECIES, 2018-2024 (USD MILLION)
TABLE 208. GERMANY LEPTOSPIROSIS VACCINE MARKET SIZE, BY ANIMAL SPECIES, 2025-2030 (USD MILLION)
TABLE 209. GERMANY LEPTOSPIROSIS VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 210. GERMANY LEPTOSPIROSIS VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 211. GERMANY LEPTOSPIROSIS VACCINE MARKET SIZE, BY INACTIVATED, 2018-2024 (USD MILLION)
TABLE 212. GERMANY LEPTOSPIROSIS VACCINE MARKET SIZE, BY INACTIVATED, 2025-2030 (USD MILLION)
TABLE 213. GERMANY LEPTOSPIROSIS VACCINE MARKET SIZE, BY RECOMBINANT, 2018-2024 (USD MILLION)
TABLE 214. GERMANY LEPTOSPIROSIS VACCINE MARKET SIZE, BY RECOMBINANT, 2025-2030 (USD MILLION)
TABLE 215. GERMANY LEPTOSPIROSIS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 216. GERMANY LEPTOSPIROSIS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 217. GERMANY LEPTOSPIROSIS VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 218. GERMANY LEPTOSPIROSIS VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 219. GERMANY LEPTOSPIROSIS VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 220. GERMANY LEPTOSPIROSIS VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 221. GERMANY LEPTOSPIROSIS VACCINE MARKET SIZE, BY DOSE FORM, 2018-2024 (USD MILLION)
TABLE 222. GERMANY LEPTOSPIROSIS VACCINE MARKET SIZE, BY DOSE FORM, 2025-2030 (USD MILLION)
TABLE 223. FRANCE LEPTOSPIROSIS VACCINE MARKET SIZE, BY ANIMAL SPECIES, 2018-2024 (USD MILLION)
TABLE 224. FRANCE LEPTOSPIROSIS VACCINE MARKET SIZE, BY ANIMAL SPECIES, 2025-2030 (USD MILLION)
TABLE 225. FRANCE LEPTOSPIROSIS VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 226. FRANCE LEPTOSPIROSIS VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 227. FRANCE LEPTOSPIROSIS VACCINE MARKET SIZE, BY INACTIVATED, 2018-2024 (USD MILLION)
TABLE 228. FRANCE LEPTOSPIROSIS VACCINE MARKET SIZE, BY INACTIVATED, 2025-2030 (USD MILLION)
TABLE 229. FRANCE LEPTOSPIROSIS VACCINE MARKET SIZE, BY RECOMBINANT, 2018-2024 (USD MILLION)
TABLE 230. FRANCE LEPTOSPIROSIS VACCINE MARKET SIZE, BY RECOMBINANT, 2025-2030 (USD MILLION)
TABLE 231. FRANCE LEPTOSPIROSIS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 232. FRANCE LEPTOSPIROSIS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 233. FRANCE LEPTOSPIROSIS VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 234. FRANCE LEPTOSPIROSIS VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 235. FRANCE LEPTOSPIROSIS VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 236. FRANCE LEPTOSPIROSIS VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 237. FRANCE LEPTOSPIROSIS VACCINE MARKET SIZE, BY DOSE FORM, 2018-2024 (USD MILLION)
TABLE 238. FRANCE LEPTOSPIROSIS VACCINE MARKET SIZE, BY DOSE FORM, 2025-2030 (USD MILLION)
TABLE 239. RUSSIA LEPTOSPIROSIS VACCINE MARKET SIZE, BY ANIMAL SPECIES, 2018-2024 (USD MILLION)
TABLE 240. RUSSIA LEPTOSPIROSIS VACCINE MARKET SIZE, BY ANIMAL SPECIES, 2025-2030 (USD MILLION)
TABLE 241. RUSSIA LEPTOSPIROSIS VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 242. RUSSIA LEPTOSPIROSIS VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 243. RUSSIA LEPTOSPIROSIS VACCINE MARKET SIZE, BY INACTIVATED, 2018-2024 (USD MILLION)
TABLE 244. RUSSIA LEPTOSPIROSIS VACCINE MARKET SIZE, BY INACTIVATED, 2025-2030 (USD MILLION)
TABLE 245. RUSSIA LEPTOSPIROSIS VACCINE MARKET SIZE, BY RECOMBINANT, 2018-2024 (USD MILLION)
TABLE 246. RUSSIA LEPTOSPIROSIS VACCINE MARKET SIZE, BY RECOMBINANT, 2025-2030 (USD MILLION)
TABLE 247. RUSSIA LEPTOSPIROSIS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 248. RUSSIA LEPTOSPIROSIS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 249. RUSSIA LEPTOSPIROSIS VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 250. RUSSIA LEPTOSPIROSIS VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 251. RUSSIA LEPTOSPIROSIS VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 252. RUSSIA LEPTOSPIROSIS VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 253. RUSSIA LEPTOSPIROSIS VACCINE MARKET SIZE, BY DOSE FORM, 2018-2024 (USD MILLION)
TABLE 254. RUSSIA LEPTOSPIROSIS VACCINE MARKET SIZE, BY DOSE FORM, 2025-2030 (USD MILLION)
TABLE 255. ITALY LEPTOSPIROSIS VACCINE MARKET SIZE, BY ANIMAL SPECIES, 2018-2024 (USD MILLION)
TABLE 256. ITALY LEPTOSPIROSIS VACCINE MARKET SIZE, BY ANIMAL SPECIES, 2025-2030 (USD MILLION)
TABLE 257. ITALY LEPTOSPIROSIS VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 258. ITALY LEPTOSPIROSIS VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 259. ITALY LEPTOSPIROSIS VACCINE MARKET SIZE, BY INACTIVATED, 2018-2024 (USD MILLION)
TABLE 260. ITALY LEPTOSPIROSIS VACCINE MARKET SIZE, BY INACTIVATED, 2025-2030 (USD MILLION)
TABLE 261. ITALY LEPTOSPIROSIS VACCINE MARKET SIZE, BY RECOMBINANT, 2018-2024 (USD MILLION)
TABLE 262. ITALY LEPTOSPIROSIS VACCINE MARKET SIZE, BY RECOMBINANT, 2025-2030 (USD MILLION)
TABLE 263. ITALY LEPTOSPIROSIS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 264. ITALY LEPTOSPIROSIS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 265. ITALY LEPTOSPIROSIS VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 266. ITALY LEPTOSPIROSIS VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 267. ITALY LEPTOSPIROSIS VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 268. ITALY LEPTOSPIROSIS VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 269. ITALY LEPTOSPIROSIS VACCINE MARKET SIZE, BY DOSE FORM, 2018-2024 (USD MILLION)
TABLE 270. ITALY LEPTOSPIROSIS VACCINE MARKET SIZE, BY DOSE FORM, 2025-2030 (USD MILLION)
TABLE 271. SPAIN LEPTOSPIROSIS VACCINE MARKET SIZE, BY ANIMAL SPECIES, 2018-2024 (USD MILLION)
TABLE 272. SPAIN LEPTOSPIROSIS VACCINE MARKET SIZE, BY ANIMAL SPECIES, 2025-2030 (USD MILLION)
TABLE 273. SPAIN LEPTOSPIROSIS VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 274. SPAIN LEPTOSPIROSIS VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 275. SPAIN LEPTOSPIROSIS VACCINE MARKET SIZE, BY INACTIVATED, 2018-2024 (USD MILLION)
TABLE 276. SPAIN LEPTOSPIROSIS VACCINE MARKET SIZE, BY INACTIVATED, 2025-2030 (USD MILLION)
TABLE 277. SPAIN LEPTOSPIROSIS VACCINE MARKET SIZE, BY RECOMBINANT, 2018-2024 (USD MILLION)
TABLE 278. SPAIN LEPTOSPIROSIS VACCINE MARKET SIZE, BY RECOMBINANT, 2025-2030 (USD MILLION)
TABLE 279. SPAIN LEPTOSPIROSIS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 280. SPAIN LEPTOSPIROSIS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 281. SPAIN LEPTOSPIROSIS VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 282. SPAIN LEPTOSPIROSIS VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 283. SPAIN LEPTOSPIROSIS VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 284. SPAIN LEPTOSPIROSIS VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 285. SPAIN LEPTOSPIROSIS VACCINE MARKET SIZE, BY DOSE FORM, 2018-2024 (USD MILLION)
TABLE 286. SPAIN LEPTOSPIROSIS VACCINE MARKET SIZE, BY DOSE FORM, 2025-2030 (USD MILLION)
TABLE 287. UNITED ARAB EMIRATES LEPTOSPIROSIS VACCINE MARKET SIZE, BY ANIMAL SPECIES, 2018-2024 (USD MILLION)
TABLE 288. UNITED ARAB EMIRATES LEPTOSPIROSIS VACCINE MARKET SIZE, BY ANIMAL SPECIES, 2025-2030 (USD MILLION)
TABLE 289. UNITED ARAB EMIRATES LEPTOSPIROSIS VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 290. UNITED ARAB EMIRATES LEPTOSPIROSIS VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 291. UNITED ARAB EMIRATES LEPTOSPIROSIS VACCINE MARKET SIZE, BY INACTIVATED, 2018-2024 (USD MILLION)
TABLE 292. UNITED ARAB EMIRATES LEPTOSPIROSIS VACCINE MARKET SIZE, BY INACTIVATED, 2025-2030 (USD MILLION)
TABLE 293. UNITED ARAB EMIRATES LEPTOSPIROSIS VACCINE MARKET SIZE, BY RECOMBINANT, 2018-2024 (USD MILLION)
TABLE 294. UNITED ARAB EMIRATES LEPTOSPIROSIS VACCINE MARKET SIZE, BY RECOMBINANT, 2025-2030 (USD MILLION)
TABLE 295. UNITED ARAB EMIRATES LEPTOSPIROSIS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 296. UNITED ARAB EMIRATES LEPTOSPIROSIS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 297. UNITED ARAB EMIRATES LEPTOSPIROSIS VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 298. UNITED ARAB EMIRATES LEPTOSPIROSIS VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 299. UNITED ARAB EMIRATES LEPTOSPIROSIS VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 300. UNITED ARAB EMIRATES LEPTOSPIROSIS VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 301. UNITED ARAB EMIRATES LEPTOSPIROSIS VACCINE MARKET SIZE, BY DOSE FORM, 2018-2024 (USD MILLION)
TABLE 302. UNITED ARAB EMIRATES LEPTOSPIROSIS VACCINE MARKET SIZE, BY DOSE FORM, 2025-2030 (USD MILLION)
TABLE 303. SAUDI ARABIA LEPTOSPIROSIS VACCINE MARKET SIZE, BY ANIMAL SPECIES, 2018-2024 (USD MILLION)
TABLE 304. SAUDI ARABIA LEPTOSPIROSIS VACCINE MARKET SIZE, BY ANIMAL SPECIES, 2025-2030 (USD MILLION)
TABLE 305. SAUDI ARABIA LEPTOSPIROSIS VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 306. SAUDI ARABIA LEPTOSPIROSIS VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 307. SAUDI ARABIA LEPTOSPIROSIS VACCINE MARKET SIZE, BY INACTIVATED, 2018-2024 (USD MILLION)
TABLE 308. SAUDI ARABIA LEPTOSPIROSIS VACCINE MARKET SIZE, BY INACTIVATED, 2025-2030 (USD MILLION)
TABLE 309. SAUDI ARABIA LEPTOSPIROSIS VACCINE MARKET SIZE, BY RECOMBINANT, 2018-2024 (USD MILLION)
TABLE 310. SAUDI ARABIA LEPTOSPIROSIS VACCINE MARKET SIZE, BY RECOMBINANT, 2025-2030 (USD MILLION)
TABLE 311. SAUDI ARABIA LEPTOSPIROSIS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 312. SAUDI ARABIA LEPTOSPIROSIS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 313. SAUDI ARABIA LEPTOSPIROSIS VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 314. SAUDI ARABIA LEPTOSPIROSIS VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 315. SAUDI ARABIA LEPTOSPIROSIS VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 316. SAUDI ARABIA LEPTOSPIROSIS VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 317. SAUDI ARABIA LEPTOSPIROSIS VACCINE MARKET SIZE, BY DOSE FORM, 2018-2024 (USD MILLION)
TABLE 318. SAUDI ARABIA LEPTOSPIROSIS VACCINE MARKET SIZE, BY DOSE FORM, 2025-2030 (USD MILLION)
TABLE 319. SOUTH AFRICA LEPTOSPIROSIS VACCINE MARKET SIZE, BY ANIMAL SPECIES, 2018-2024 (USD MILLION)
TABLE 320. SOUTH AFRICA LEPTOSPIROSIS VACCINE MARKET SIZE, BY ANIMAL SPECIES, 2025-2030 (USD MILLION)
TABLE 321. SOUTH AFRICA LEPTOSPIROSIS VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 322. SOUTH AFRICA LEPTOSPIROSIS VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 323. SOUTH AFRICA LEPTOSPIROSIS VACCINE MARKET SIZE, BY INACTIVATED, 2018-2024 (USD MILLION)
TABLE 324. SOUTH AFRICA LEPTOSPIROSIS VACCINE MARKET SIZE, BY INACTIVATED, 2025-2030 (USD MILLION)
TABLE 325. SOUTH AFRICA LEPTOSPIROSIS VACCINE MARKET SIZE, BY RECOMBINANT, 2018-2024 (USD MILLION)
TABLE 326. SOUTH AFRICA LEPTOSPIROSIS VACCINE MARKET SIZE, BY RECOMBINANT, 2025-2030 (USD MILLION)
TABLE 327. SOUTH AFRICA LEPTOSPIROSIS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 328. SOUTH AFRICA LEPTOSPIROSIS VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 329. SOUTH AFRICA LEPTOSPIROSIS VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 330. SOUTH AFRICA LEPTOSPIROSIS VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MIL

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Leptospirosis Vaccine market report include:
  • Zoetis Inc.
  • Merck & Co., Inc.
  • Boehringer Ingelheim International GmbH
  • Elanco Animal Health Incorporated
  • CEVA SANTE ANIMALE S.A.
  • Laboratorios Hipra, S.A.
  • IDT Biologika GmbH
  • VAXXINOVA GmbH
  • Indian Immunologicals Limited
  • Anhui Zhonglong Bio-science Stock Co., Ltd.

Related Topics

Related Reports

Veterinary Lyme Disease Vaccine Market - Global Forecast 2025-2030 - Product Image

Veterinary Lyme Disease Vaccine Market - Global Forecast 2025-2030

  • Report
  • 183 Pages
  • Global
From
Canine Vaccine Market - Global Forecast 2025-2030 - Product Image

Canine Vaccine Market - Global Forecast 2025-2030

  • Report
  • 181 Pages
  • Global
From
Dog Vaccines Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Dog Vaccines Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 185 Pages
  • Global
From
Dog Vaccine - Global Strategic Business Report - Product Image

Dog Vaccine - Global Strategic Business Report

  • Report
  • 576 Pages
  • Global
From
Ruminant Vaccines - Global Strategic Business Report - Product Image

Ruminant Vaccines - Global Strategic Business Report

  • Report
  • 563 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.